Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a Protocol

Overview

Journal BMJ Open

Specialty General Medicine

Date 2021 Jul 30

PMID 34326050

Citations 13

Authors

Shankar Prinja

Jyoti Dixit

Nidhi Gupta

Nikita Mehra

Ashish Singh

Manjunath Nookala Krishnamurthy

Dharna Gupta

Kavitha Rajsekar

Jayachandran Perumal Kalaiyarasi

Partha Sarathi Roy

Prabhat Singh Malik

Anisha Mathew

Awadhesh Pandey

Pankaj Malhotra

Sudeep Gupta

Lalit Kumar

Amal Kataki

Gurpreet Singh

Affiliations

Soon will be listed here.

Abstract

Introduction: The rising economic burden of cancer on healthcare system and patients in India has led to the increased demand for evidence in order to inform policy decisions such as drug price regulation, setting reimbursement package rates under publicly financed health insurance schemes and prioritising available resources to maximise value of investments in health. Economic evaluations are an integral component of this important evidence. Lack of existing evidence on healthcare costs and health-related quality of life (HRQOL) makes conducting economic evaluations a very challenging task. Therefore, it is imperative to develop a national database for health expenditure and HRQOL for cancer.

Methods And Analysis: The present study proposes to develop a National Cancer Database for Cost and Quality of Life (CaDCQoL) in India. The healthcare costs will be estimated using a patient perspective. A cross-sectional study will be conducted to assess the direct out-of-pocket expenditure (OOPE), indirect cost and HRQOL among cancer patients who will be recruited at seven leading cancer centres from six states in India. Mean OOPE and HRQOL scores will be estimated by cancer site, stage of disease and type of treatment. Economic impact of cancer care on household financial risk protection will be assessed by estimating prevalence of catastrophic health expenditures and impoverishment. The national database would serve as a unique open access data repository to derive estimates of cancer-related OOPE and HRQOL. These estimates would be useful in conducting future cost-effectiveness analyses of management strategies for value-based cancer care.

Ethics And Dissemination: Approval was granted by Institutional Ethics Committee vide letter no. PGI/IEC-03/2020-1565 of Post Graduate Institute of Medical Education and Research, Chandigarh, India. The study results will be published in peer-reviewed journals and presented to the policymakers at national level.

Citing Articles

Access to timely cancer treatment initiation in India: extent, determinants and trends.

Halder P, Dixit J, Gupta N, Mehra N, Singh A, Malhotra P Lancet Reg Health Southeast Asia. 2025; 32:100514.

PMID: 39802701 PMC: 11722993. DOI: 10.1016/j.lansea.2024.100514.

Dixit J, Gupta N, Kataki A, Roy P, Mehra N, Kumar L Health Qual Life Outcomes. 2024; 22(1):26.

PMID: 38481231 PMC: 10938809. DOI: 10.1186/s12955-024-02227-0.

Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India.

Wadhwa R, Gupta N, Dixit J, Malhotra P, Lakshmi P, Prinja S JCO Glob Oncol. 2024; 10:e2300396.

PMID: 38452304 PMC: 10939583. DOI: 10.1200/GO.23.00396.

Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India.

Gupta D, Gupta N, Singh N, Prinja S JCO Glob Oncol. 2024; 10:e2300260.

PMID: 38359374 PMC: 10881089. DOI: 10.1200/GO.23.00260.

Cost-Effectiveness Analysis of Systemic Therapy for Intensification of Treatment in Metastatic Hormone-Sensitive Prostate Cancer in India.

Gupta N, Gupta D, Vaska K, Prinja S Appl Health Econ Health Policy. 2024; 22(3):415-426.

PMID: 38198103 DOI: 10.1007/s40258-023-00866-w.

References

Rajpal S, Kumar A, Joe W . Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014. PLoS One. 2018; 13(2):e0193320. PMC: 5826535. DOI: 10.1371/journal.pone.0193320. View

Bahuguna P, Guinness L, Sharma S, Chauhan A, Downey L, Prinja S . Estimating the Unit Costs of Healthcare Service Delivery in India: Addressing Information Gaps for Price Setting and Health Technology Assessment. Appl Health Econ Health Policy. 2020; 18(5):699-711. PMC: 7519005. DOI: 10.1007/s40258-020-00566-9. View

Prinja S, Jagnoor J, Sharma D, Aggarwal S, Katoch S, Lakshmi P . Out-of-pocket expenditure and catastrophic health expenditure for hospitalization due to injuries in public sector hospitals in North India. PLoS One. 2019; 14(11):e0224721. PMC: 6837486. DOI: 10.1371/journal.pone.0224721. View

Chauhan A, Prinja S, Srinivasan R, Rai B, Malliga J, Jyani G . Cost effectiveness of strategies for cervical cancer prevention in India. PLoS One. 2020; 15(9):e0238291. PMC: 7462298. DOI: 10.1371/journal.pone.0238291. View

Brooks R . EuroQol: the current state of play. Health Policy. 1996; 37(1):53-72. DOI: 10.1016/0168-8510(96)00822-6. View

Mehlis K, Witte J, Surmann B, Kudlich M, Apostolidis L, Walther J . The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients. BMC Cancer. 2020; 20(1):529. PMC: 7275553. DOI: 10.1186/s12885-020-07028-4. View

Prinja S, Chauhan A, Rajsekhar K, Downey L, Bahuguna P, Sachin O . Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to Action. Value Health Reg Issues. 2020; 21:226-229. DOI: 10.1016/j.vhri.2019.11.003. View

Carrera P, Kantarjian H, Blinder V . The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018; 68(2):153-165. PMC: 6652174. DOI: 10.3322/caac.21443. View

Moreno-Serra R, Millett C, Smith P . Towards improved measurement of financial protection in health. PLoS Med. 2011; 8(9):e1001087. PMC: 3167798. DOI: 10.1371/journal.pmed.1001087. View

10.

Fryback D, Craig B . Measuring economic outcomes of cancer. J Natl Cancer Inst Monogr. 2004; (33):134-41. DOI: 10.1093/jncimonographs/lgh018. View

11.

Downey L, Rao N, Guinness L, Asaria M, Prinja S, Sinha A . Identification of publicly available data sources to inform the conduct of Health Technology Assessment in India. F1000Res. 2018; 7:245. PMC: 5930391. DOI: 10.12688/f1000research.14041.2. View

12.

Kastor A, Mohanty S . Disease-specific out-of-pocket and catastrophic health expenditure on hospitalization in India: Do Indian households face distress health financing?. PLoS One. 2018; 13(5):e0196106. PMC: 5945043. DOI: 10.1371/journal.pone.0196106. View

13.

Gerlinger C, Bamber L, Leverkus F, Schwenke C, Haberland C, Schmidt G . Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results. BMC Res Notes. 2019; 12(1):18. PMC: 6332559. DOI: 10.1186/s13104-019-4067-9. View

14.

Singh M, Chauhan A, Rai B, Ghoshal S, Prinja S . Cost of Treatment for Cervical Cancer in India. Asian Pac J Cancer Prev. 2020; 21(9):2639-2646. PMC: 7779435. DOI: 10.31557/APJCP.2020.21.9.2639. View

15.

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan K, Santhappan S . Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Glob Oncol. 2020; 6:1063-1075. PMC: 7392737. DOI: 10.1200/GO.20.00122. View

16.

. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016. Lancet Oncol. 2018; 19(10):1289-1306. PMC: 6167407. DOI: 10.1016/S1470-2045(18)30447-9. View

17.

Eiser C, Morse R . A review of measures of quality of life for children with chronic illness. Arch Dis Child. 2001; 84(3):205-11. PMC: 1718699. DOI: 10.1136/adc.84.3.205. View

18.

Prinja S, Singh M, Guinness L, Rajsekar K, Bhargava B . Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol. BMJ Open. 2020; 10(7):e035170. PMC: 7375634. DOI: 10.1136/bmjopen-2019-035170. View

19.

Zafar S . Financial Toxicity of Cancer Care: It's Time to Intervene. J Natl Cancer Inst. 2015; 108(5). DOI: 10.1093/jnci/djv370. View

20.

Jyani G, Prinja S, Kar S, Trivedi M, Patro B, Purba F . Valuing health-related quality of life among the Indian population: a protocol for the Development of an EQ-5D Value set for India using an Extended design (DEVINE) Study. BMJ Open. 2021; 10(11):e039517. PMC: 7682473. DOI: 10.1136/bmjopen-2020-039517. View